Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy

Overview

Journal Front Mol Biosci

Specialty Biology

Date 2021 Jun 28

PMID 34179101

Citations 21

Authors

Maryam Omran

Elizabeth K Belcher

Nimish A Mohile

Shelli R Kesler

Michelle C Janelsins

Andrea G Hohmann

Ian R Kleckner

Affiliations

Soon will be listed here.

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is a common, debilitating, and dose-limiting side effect of many chemotherapy regimens yet has limited treatments due to incomplete knowledge of its pathophysiology. Research on the pathophysiology of CIPN has focused on peripheral nerves because CIPN symptoms are felt in the hands and feet. However, better understanding the role of the brain in CIPN may accelerate understanding, diagnosing, and treating CIPN. The goals of this review are to (1) investigate the role of the brain in CIPN, and (2) use this knowledge to inform future research and treatment of CIPN. We identified 16 papers using brain interventions in animal models of CIPN and five papers using brain imaging in humans or monkeys with CIPN. These studies suggest that CIPN is partly caused by (1) brain hyperactivity, (2) reduced GABAergic inhibition, (3) neuroinflammation, and (4) overactivation of GPCR/MAPK pathways. These four features were observed in several brain regions including the thalamus, periaqueductal gray, anterior cingulate cortex, somatosensory cortex, and insula. We discuss how to leverage this knowledge for future preclinical research, clinical research, and brain-based treatments for CIPN.

Citing Articles

Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy.

Wong M, Widerstrom-Noga E, Bolanos J, Gonzalez G, Penedo F, Hosein P Front Pain Res (Lausanne). 2025; 5:1516196.

PMID: 39896735 PMC: 11782131. DOI: 10.3389/fpain.2024.1516196.

Efficacy of GABA aminotransferase inactivator OV329 in models of neuropathic and inflammatory pain without tolerance or addiction.

Wirt J, Assis Ferreira L, Jesus C, Woodward T, Oliva I, Xu Z Proc Natl Acad Sci U S A. 2025; 122(1):e2318833121.

PMID: 39793055 PMC: 11725897. DOI: 10.1073/pnas.2318833121.

Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy.

Girdenyte M, Hu Y, Ginosyan A, Hammarlund-Udenaes M, Loryan I Front Pharmacol. 2024; 15:1486686.

PMID: 39568585 PMC: 11576287. DOI: 10.3389/fphar.2024.1486686.

Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system.

Kleckner I, Manuweera T, Lin P, Chung K, Kleckner A, Gewandter J Support Care Cancer. 2024; 32(10):677.

PMID: 39304604 DOI: 10.1007/s00520-024-08855-y.

Cognitive function in long-term testicular cancer survivors: impact of modifiable factors.

Dinh Jr P, Monahan P, Fung C, Sesso H, Feldman D, Vaughn D JNCI Cancer Spectr. 2024; 8(5).

PMID: 39141447 PMC: 11424079. DOI: 10.1093/jncics/pkae068.

References

Ta L, Bieber A, Carlton S, Loprinzi C, Low P, Windebank A . Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice. Mol Pain. 2010; 6:15. PMC: 2848188. DOI: 10.1186/1744-8069-6-15. View

Staff N, Grisold A, Grisold W, Windebank A . Chemotherapy-induced peripheral neuropathy: A current review. Ann Neurol. 2017; 81(6):772-781. PMC: 5656281. DOI: 10.1002/ana.24951. View

Descoeur J, Pereira V, Pizzoccaro A, Francois A, Ling B, Maffre V . Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol Med. 2011; 3(5):266-78. PMC: 3377073. DOI: 10.1002/emmm.201100134. View

Ciampi de Andrade D, Teixeira M, Galhardoni R, Ferreira K, Braz Mileno P, Scisci N . Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind Trial. Oncologist. 2017; 22(10):1154-e105. PMC: 5634769. DOI: 10.1634/theoncologist.2017-0235. View

Enna S, McCarson K . The role of GABA in the mediation and perception of pain. Adv Pharmacol. 2006; 54:1-27. DOI: 10.1016/s1054-3589(06)54001-3. View

Argyriou A, Cavaletti G, Briani C, Velasco R, Bruna J, Campagnolo M . Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. Cancer. 2012; 119(2):438-44. DOI: 10.1002/cncr.27732. View

Quartu M, Carozzi V, Dorsey S, Serra M, Poddighe L, Picci C . Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve. Biomed Res Int. 2014; 2014:180428. PMC: 4022313. DOI: 10.1155/2014/180428. View

Ng K, Ong J, Nyein Nyein T, Liang S, Chan Y, Lee K . EMLA-Induced Skin Wrinkling for the Detection of Diabetic Neuropathy. Front Neurol. 2013; 4:126. PMC: 3759298. DOI: 10.3389/fneur.2013.00126. View

Waseem M, Kaushik P, Tabassum H, Parvez S . Role of Mitochondrial Mechanism in Chemotherapy-Induced Peripheral Neuropathy. Curr Drug Metab. 2017; 19(1):47-54. DOI: 10.2174/1389200219666171207121313. View

10.

Khalsa S, Adolphs R, Cameron O, Critchley H, Davenport P, Feinstein J . Interoception and Mental Health: A Roadmap. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018; 3(6):501-513. PMC: 6054486. DOI: 10.1016/j.bpsc.2017.12.004. View

11.

Peng P, Xi Q, Xia S, Zhuang L, Gui Q, Chen Y . Pregabalin attenuates docetaxel-induced neuropathy in rats. J Huazhong Univ Sci Technolog Med Sci. 2012; 32(4):586-590. DOI: 10.1007/s11596-012-1001-y. View

12.

Morioka N, Kodama K, Tomori M, Yoshikawa K, Saeki M, Nakamura Y . Stimulation of nuclear receptor REV-ERBs suppresses production of pronociceptive molecules in cultured spinal astrocytes and ameliorates mechanical hypersensitivity of inflammatory and neuropathic pain of mice. Brain Behav Immun. 2019; 78:116-130. DOI: 10.1016/j.bbi.2019.01.014. View

13.

Nassini R, Gees M, Harrison S, De Siena G, Materazzi S, Moretto N . Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain. 2011; 152(7):1621-1631. DOI: 10.1016/j.pain.2011.02.051. View

14.

Zheng H, Xiao W, Bennett G . Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy. Exp Neurol. 2011; 232(2):154-61. PMC: 3202047. DOI: 10.1016/j.expneurol.2011.08.016. View

15.

McLeary F, Davis A, Rudrawar S, Perkins A, Anoopkumar-Dukie S . Mechanisms underlying select chemotherapeutic-agent-induced neuroinflammation and subsequent neurodegeneration. Eur J Pharmacol. 2018; 842:49-56. DOI: 10.1016/j.ejphar.2018.09.034. View

16.

Minami T, Okazaki J, Kawabata A, Kuroda R, Okazaki Y . Penetration of cisplatin into mouse brain by lipopolysaccharide. Toxicology. 1998; 130(2-3):107-13. DOI: 10.1016/s0300-483x(98)00103-6. View

17.

Nashawi H, Masocha W, Edafiogho I, Kombian S . Paclitaxel Causes Electrophysiological Changes in the Anterior Cingulate Cortex via Modulation of the γ-Aminobutyric Acid-ergic System. Med Princ Pract. 2016; 25(5):423-8. PMC: 5588502. DOI: 10.1159/000447775. View

18.

Masocha W . Gene expression profile of sodium channel subunits in the anterior cingulate cortex during experimental paclitaxel-induced neuropathic pain in mice. PeerJ. 2016; 4:e2702. PMC: 5119229. DOI: 10.7717/peerj.2702. View

19.

Branca J, Maresca M, Morucci G, Becatti M, Paternostro F, Gulisano M . Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity. Oncotarget. 2018; 9(34):23426-23438. PMC: 5955120. DOI: 10.18632/oncotarget.25193. View

20.

Flatters S, Dougherty P, Colvin L . Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review. Br J Anaesth. 2017; 119(4):737-749. DOI: 10.1093/bja/aex229. View